LK 001
Alternative Names: LK-001; UC-MSC - LiveKidney.Bio; Umbilical Cord–derived Mesenchymal Stromal Cells - LiveKidney.BioLatest Information Update: 31 Jan 2025
Price :
$50 *
At a glance
- Originator LiveKidney.Bio
- Class Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Kidney disorders; Lupus nephritis
Most Recent Events
- 20 Dec 2024 LiveKidney.Bio plans a phase I trial for Systemic lupus erythematosus in USA (SC, Injection) in January 2025 (NCT06737380 )
- 19 Dec 2024 Clinical trials in Kidney disorders (SC) prior to December 2024 (LiveKidney.Bio pipeline, December 2024)
- 19 Dec 2024 Clinical trials in Lupus nephritis (SC) prior to December 2024 (LiveKidney.Bio pipeline, December 2024)